Valuation: Guilin Sanjin Pharmaceutical Co., Ltd.

Market Cap 8.8B 1.32B 1.18B 1.09B 987M 1.85B 126B 1.88B 12.99B 5.22B 66.05B 4.96B 4.86B 208B P/E 2024
17x
P/E 2025 19.1x
Enterprise Value 7.59B 1.14B 1.02B 940M 852M 1.59B 108B 1.62B 11.21B 4.5B 56.99B 4.28B 4.19B 180B EV / Sales 2024
3.55x
EV / Sales 2025 3.46x
Free-Float
22.45%
Yield 2024
3.98%
Yield 2025 3.55%
1 day+9.99%
1 week+23.70%
Current month+22.59%
1 month+22.59%
3 months+12.89%
6 months+4.68%
Current year+6.24%
1 week 12.05
Extreme 12.05
14.98
1 month 11.82
Extreme 11.82
14.98
Current year 11.82
Extreme 11.82
14.98
1 year 11.82
Extreme 11.82
15.75
3 years 11.28
Extreme 11.28
18.35
5 years 10.59
Extreme 10.59
21.67
10 years 10.59
Extreme 10.59
21.67
Manager TitleAgeSince
Chief Executive Officer 50 -
Director of Finance/CFO 49 27/12/2025
Corporate Officer/Principal 56 26/12/2022
Director TitleAgeSince
Chairman 50 14/01/2022
Director/Board Member 46 26/12/2019
Chairman 58 26/12/2022
Date Insider Type Main position Quantity % Market Cap. Importance
4/29/24 A Buy

Chairman

148,300 0.0268%
9/29/20 A Sell

Chairperson

89,100 0.0165%
Change 5-day change 1-year change 3-year change Capi.($)
+9.99%+23.70%+1.77%+2.81% 1.32B
+3.19%+11.31%+67.86%+150.58% 1,263B
-0.73%+3.56%+44.51%+85.81% 658B
+1.41%+3.24%+29.22%+107.83% 521B
+0.42%+3.20%+54.15%+67.18% 391B
+2.18%+2.93%+73.30%+45.62% 369B
+1.12%+4.52%+35.30%+58.08% 307B
+6.96%+8.86%+11.27%+36.62% 290B
+1.15%+6.09%+59.59%+77.06% 252B
+3.06%+9.38%+44.11%+119.47% 212B
Average +2.55%+7.54%+42.11%+75.11% 426.33B
Weighted average by Cap. +1.20%+6.60%+50.86%+98.28%

Financials

2024 2025
Net sales 2.19B 330M 295M 272M 246M 460M 31.3B 469M 3.24B 1.3B 16.46B 1.24B 1.21B 51.92B 2.05B 307M 275M 253M 229M 429M 29.18B 437M 3.02B 1.21B 15.35B 1.15B 1.13B 48.41B
Net income 522M 78.36M 70.18M 64.55M 58.49M 109M 7.44B 111M 770M 309M 3.91B 294M 288M 12.34B 433M 65.08M 58.28M 53.61M 48.58M 90.8M 6.18B 92.5M 639M 257M 3.25B 244M 239M 10.25B
Net Debt -1.08B -163M -146M -134M -121M -227M -15.44B -231M -1.6B -641M -8.12B -610M -597M -25.61B -1.21B -181M -162M -149M -135M -253M -17.23B -258M -1.78B -715M -9.06B -681M -666M -28.58B
Projected Income Statement - Annual - Guilin Sanjin Pharmaceutical Co., Ltd.
Logo Guilin Sanjin Pharmaceutical Co., Ltd.
Guilin Sanjin Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, manufacturing and sales of Chinese patent medicines. The Company mainly operates in the two major areas of oral and throat health and urinary health, including the prevention, self-treatment and rehabilitation of common household diseases such as cardiovascular and cerebrovascular, nervous system, respiratory system and digestive system. The Company's main products include Sanjin Tablets, Guilin Xiguashuang, Xiguashuang Throat Tablets, Xiguashuang Qingyan Lozenges, Naomaitai Capsules, Xuanyunning Tablets/Granules, Gejie Dingchuan Capsules, Yuye Jiedu Granules.
Employees
2,556
Date Price Change Volume
30/10/26 CN¥14.98 +9.99% 23,626,095
29/10/26 CN¥13.62 +10.02% 23,125,663
28/10/26 CN¥12.38 +2.57% 3,485,190
27/10/26 CN¥12.07 -1.47% 1,133,400
26/10/26 CN¥12.25 +1.16% 1,361,502

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Guilin Sanjin Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002275 Stock